Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464

Protein Science

Volumn 20, Issue 1, 2011, Pages 210-215

  Hall, Gareth ^a   Bradshaw, Tracey D ^a   Laughton, Charles A ^a   Stevens, Malcolm F ^a   Emsley, Jonas ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Inhibitor complex; Mycobacterium tuberculosis; Quinol; Thioredoxin

Indexed keywords

HOMODIMER; PMX 464; PROTEIN INHIBITOR; THIOREDOXIN; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG STRUCTURE; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

BACTERIAL PROTEINS; BENZOTHIAZOLES; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROQUINONES; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BINDING; PROTEIN CONFORMATION; THIOREDOXINS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 78650783356     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.533     Document Type: Article

References (28)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686.
2. Glickman MS, Jacobs WR, Jr (2001) Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104: 477-485.
3. Gordon AH, Hart PD (1994) Stimulation or inhibition of the respiratory burst in cultured macrophages in a mycobacterium model: initial stimulation is followed by inhibition after phagocytosis. Infect Immun 62: 4650-4651.
4. Chen L, Xie QW, Nathan C (1998) Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell 1: 795-805.
5. Shinnick TM, King CH, Quinn FD (1995) Molecular biology, virulence, and pathogenicity of mycobacteria. Am J Med Sci 309: 92-98.
6. Rouse DA, Morris SL (1995) Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect Immun 63: 1427-1433.
7. Middlebrook G (1952) Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc 65: 765-767.
8. Wengenack NL, Rusnak F (2001) Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazidresistant mutant KatG(S315T). Biochemistry 40: 8990-8996.
9. Guimaraes BG, Souchon H, Honore N, Saint-Joanis B, Brosch R, Shepard W, Cole ST, Alzari PM (2005) Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress. J Biol Chem 280: 25735-25742.
10. Akif M, Khare G, Tyagi AK, Mande SC, Sardesai AA (2008) Functional studies of multiple thioredoxins from Mycobacterium tuberculosis. J Bacteriol 190: 7087-7095.
11. Zhang Z, Hillas PJ, Ortiz de Montellano PR (1999) Reduction of peroxides and dinitrobenzenes by Mycobacterium tuberculosis thioredoxin and thioredoxin reductase. Arch Biochem Biophys 363: 19-26.
12. Jaeger T, Budde H, Flohe L, Menge U, Singh M, Trujillo M, Radi R (2004) Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. Arch Biochem Biophys 423: 182-191.
13. Hall G, Shah M, McEwan PA, Laughton C, Stevens M, Westwell A, Emsley J (2006) Structure of Mycobacterium tuberculosis thioredoxin C. Acta Crystallogr D Biol Crystallogr 62: 1453-1457.
14. Eklund H, Gleason FK, Holmgren A (1991) Structural and functional relations among thioredoxins of different species. Proteins 11: 13-28.
15. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54: 237-271.
16. Holmgren A (1989) Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966.
17. Shah M, Wells G, Bradshaw TD, Laughton CA, Stevens MFG, Westwell AD (2006) Antitubercular properties of substituted hydroxycyclohexadienones. Lett Drug Des Discov 3: 419-423.
18. Bradshaw TD, Matthews CS, Cookson J, Chew EH, Shah M, Bailey K, Monks A, Harris E, Westwell AD, Wells G, Laughton CA, Stevens MF (2005) Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res 65: 3911-3919.
19. Chartron J, Shiau C, Stout CD, Carroll KS (2007) 3́- Phosphoadenosine-5́-phosphosulfate reductase in complex with thioredoxin: a structural snapshot in the catalytic cycle. Biochemistry 46: 3942-3951.
20. Qin J, Clore GM, Kennedy WM, Huth JR, Gronenborn AM (1995) Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3: 289-297.
21. Qin J, Clore GM, Kennedy WP, Kuszewski J, Gronenborn AM (1996) The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure 4: 613-620.
22. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8: 127-134.
23. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, III, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
24. Leslie AGW (1998) MOSFLM v.6.0., MRC Laboratory of Molecular Chemistry, Cambridge.
25. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61: 458-464.
26. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
27. Afonine PV, Grosse-Kunstleve RW, Adams PD (2005) Phenix. CCP4 Newsl. 42, contribution 8.
28. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.